Philippe D. Violette
McMaster University
92 Papers
187 Citations
Philippe D. Violette is an academic researcher from McMaster University. The author has contributed to research in topics: Medicine & Guideline. The author has an hindex of 17, co-authored 65 publications. Previous affiliations of Philippe D. Violette include University of Western Ontario & McGill University.
Chat about Author
Papers
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
Thomas B. Lam,Thomas B. Lam,Steven MacLennan,Peter Paul M. Willemse,Malcolm David Mason,Karin Plass,Robert Shepherd,Ruud Baanders,Chris H. Bangma,Anders Bjartell,Alberto Bossi,Erik Briers,Alberto Briganti,Karel Tim Buddingh,James W.F. Catto,James W.F. Catto,Maurizio Colecchia,Brett Cox,Marcus G. Cumberbatch,Jeff Davies,Niall F. Davis,Maria De Santis,Paolo Dell'Oglio,André Deschamps,James Donaldson,James Donaldson,Shin Egawa,Christian D. Fankhauser,Stefano Fanti,Nicola Fossati,Giorgio Gandaglia,Silke Gillessen,Silke Gillessen,Nikolaos Grivas,Tobias Gross,Jeremy Grummet,Ann Henry,Alexandre Ingels,Jacques Irani,Michael Lardas,Matthew Liew,Daniel W. Lin,Daniel W. Lin,Lisa Moris,Muhammad Imran Omar,Karl H. Pang,Catherine Paterson,Catherine Paterson,Catherine Paterson,Raphaële Renard-Penna,Maria J. Ribal,Monique J. Roobol,Morgan Rouprêt,Olivier Rouvière,Gemma Sancho Pardo,Jonathan Richenberg,Ivo G. Schoots,J.P. Michiel Sedelaar,Phillip D. Stricker,Derya Tilki,Susanne Vahr Lauridsen,Roderick C.N. van den Bergh,Thomas Van den Broeck,Theodorus H. van der Kwast,Henk G. van der Poel,Geert J.L.H. van Leenders,Murali Varma,Philippe D. Violette,Christopher J.D. Wallis,Christopher J.D. Wallis,Thomas Wiegel,Karen Wilkinson,Fabio Zattoni,James N'Dow,James N'Dow,Hendrik Van Poppel,Philip Cornford,Nicolas Mottet +77 more
TL;DR: Consensus statements and the findings are expected to guide and inform routine clinical practice and research, until higher levels of evidence emerge through prospective comparative studies and clinical trials.
194
Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis.
Philippe D. Violette,Thomas Agoritsas,Paul E. Alexander,Jarno Riikonen,Henrikki Santti,Arnav Agarwal,Neera Bhatnagar,Philipp Dahm,Victor M. Montori,Gordon H. Guyatt,Kari A.O. Tikkinen +10 more
TL;DR: Because current decision aids provide information but do not directly facilitate shared decision making, subsequent efforts would benefit from user‐centered design of decision aids that promote shared decisionMaking.
138
Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery
Kari A.O. Tikkinen,Samantha Craigie,Arnav Agarwal,Philippe D. Violette,Giacomo Novara,Rufus Cartwright,Richard Naspro,Reed A C Siemieniuk,Bassel Ali,Leyla Eryuzlu,Johanna Geraci,Judi Winkup,Daniel Yoo,Michael K. Gould,Per Morten Sandset,Gordon H. Guyatt +15 more
100
Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study.
Darryl P. Leong,Vincent Fradet,Bobby Shayegan,Emmanuelle Duceppe,Robert Siemens,Tamim Niazi,Laurence Klotz,Ian Brown,Joseph L. Chin,Luke T. Lavallée,Negareh Mousavi,Patrick Luke,Himu Lukka,Darin Gopaul,Philippe D. Violette,Robert J. Hamilton,Margot K. Davis,Sarah Karampatos,Rajibul Mian,Guila Delouya,Yves Fradet,Som D. Mukherjee,David Conen,Annabel Chen-Tournoux,Chris A. Johnson,Amal Bessissow,George K. Dresser,Adnan Kazi Hameed,Husam Abdel-Qadir,Alp Sener,Raveen Pal,Philip J. Devereaux,Jehonathan H. Pinthus +32 more
TL;DR: Two-thirds of men with prostate cancer is at high cardiovascular risk; there is a positive association between a plan to use ADT and baseline cardiovascular risk factors; however, this association is explained by confounding factors.
91
Guideline of guidelines: thromboprophylaxis for urological surgery
Philippe D. Violette,Rufus Cartwright,Rufus Cartwright,Matthias Briel,Kari A.O. Tikkinen,Gordon H. Guyatt +5 more
TL;DR: A systematic review of the literature revealed that existing guidelines in urology are limited, which may result in the under‐ treatment of procedures with low risk of bleeding and the over‐treatment of oncological procedures withLow risk of VTE.
78